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Abstract
The 2009 pandemic H1N1 influenza virus encodes an NS1 protein with 11 amino acids (aa) truncation at the C-terminus. The
C-terminal tail of influenza virus NS1 protein constitutes a nucleolar localization signal (NoLS) and is the binding domain of
the cellular pre-mRNA processing protein, poly(A)-binding protein II (PABII). Here, our studies showed that the C-terminal-
truncated NS1 of the 2009 pandemic virus was inefficient at blocking host gene expression, extension of the truncated NS1
to its full length increased the inhibition of host gene expression. Mechanistically, this increased inhibition of host gene
expression by the full-length NS1 was not associated with nucleolar localization, but was due to the restoration of NS1’s
binding capacity to PABII. Furthermore, in vitro and in vivo characterization of two recombinant viruses encoding either the
C-terminal 11-aa truncated or full-length NS1 of the 2009 pandemic virus showed that the C-terminal 11-aa truncation in
NS1 did not significantly alter virus replication, but increased virus pathogenicity in mice.
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Introduction
A novel swine-origin H1N1 influenza virus emerged in Mexico
in April 2009 [1–2] and had spread globally prompting the World
Health Organization (WHO) to raise this global pandemic to
phase 6. Although it caused mild disease in the majority of people,
the 2009 pandemic virus was more pathogenic and induced higher
amounts of pro-inflammatory cytokines and chemokines in
mammalian models than human seasonal H1N1 influenza viruses
[3]. Interestingly, the majority of human seasonal H1N1 influenza
viruses encoded a 230-aa NS1, while the 2009 pandemic H1N1
influenza virus encoded a 219-aa NS1 with an 11-aa truncation at
the C-terminus [4].
The NS1 of influenza virus is a multifunctional protein that
performs a number of activities, which may contribute to efficient
virus replication and virulence during infection [5]. NS1 protein
inhibits host antiviral gene expression by both pre-transcriptional
and post-transcriptional processes. The pre-transcriptional inhibi-
tion occurs by preventing dsRNA- and virus-mediated activation
of the transcription factors (IRF-3, NF-kB and c-Jun/ATF-2),
which are essential for IFN-b production [6–8], while the post-
transcriptional inhibition is involved in limiting cellular mRNA
maturation and nucleo-cytoplasmic transport through interaction
of NS1 protein with the 30 KD cleavage and polyadenylation
specificity factor (CPSF30) or PABII [9–10]. In addition, NS1 can
block the function of two antiviral proteins including 29-59-
oligoadenylate synthetase (OAS) [11] and serine/threonine
protein kinase R (PKR) [12], stimulate phosphoinositide 3-kinase
signaling (PI3K) by binding to p85b and/or CrkL [13–16], and
limit host antiviral gene translation by binding to eIF4GI [17].
The influenza virus NS1 contains two nuclear localization
signals (NLS), which mediate the active nuclear import of NS1 via
binding to celluar impotin-a [5]. The NLS1 is located in the N-
terminal RNA-binding domain, while the NLS2 is located at the
C-terminus. Certain critical amino acids (219K, 220R, 224R and
229K) of the C-terminal NLS2 constitute an NoLS [18]. The C-
terminal 11-aa truncation (220-230) in NS1 of the 2009 pandemic
virus might have lost the NoLS and affect intracellular localization
of the NS1 protein.
In most eukaryotic cells, CPSF, cleavage stimulation factor
(CstF), cleavage factors I and II (CFI and II) and poly(A)
polymerase (PAP) are usually required for the cleavage of host
pre-mRNAs and adding a short (,10 nucleotide) poly(A) tail.
Subsequent elongation of this short poly(A) tail requires PABII,
CPSF and PAP, which facilitate rapid, processive poly(A) addition
[9–10]. In addition, PABII also plays a role in nuclear export of
host mRNA. Influenza virus NS1 can bind to CPSF30 and PABII
and thus inhibits host pre-mRNA processing. The C-terminal
amino acids 223-230 of NS1 constitute the PABII binding domain
[5]. Whether the C-terminal 11-aa truncated NS1 of the 2009
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determined.
Here, we assessed the effects of the C-terminal 11-aa truncation
in NS1 of the 2009 pandemic virus on host gene expression,
nucleolar localization, PABII-binding capacity as well as virus
replication and pathogenicity. In this study, we found that the C-
terminal 11-aa truncated NS1 was inefficient at blocking host gene
expression, failed to localized in nucleolus and lost the PABII-
binding capacity. Extension of the C-terminal truncated NS1 to its
full length increased the inhibition of host gene expression,
restored PABII-binding capacity, but still did not localize in
nucleolus. Moreover, the NS1 C-terminal 11-aa truncation did not
significantly alter virus replication in vitro or in vivo, but enhanced
virus virulence in mice.
Materials and Methods
Cells and plasmids
Human embryonic kidney (293T) cells, human lung epithelial
(A549) cells, porcine kidney (PK-15) cells and Madin-Darby
canine kidney (MDCK) cells were obtained from the American
Type Culture Collection (ATCC) and maintained in Dulbecco’s
minimal essential medium (DMEM) (Invitrogen) with 10% fetal
bovine serum (GIBCO, Auckland, NZ). The pHW-Mex NS
plasmid was constructed by synthesizing the sequence of NS gene
(accession number: GQ379816.1) from the 2009 pandemic virus
A/Mexico/4486/2009 H1N1 (Mex) and cloning it into the
pHW2000 plasmid as described previously [19]. A QuikChange
XL site-directed mutagenesis kit (Stratagene, La Jolla, CA) was
used to generate a mutant plasmid pHW-Mex mNS, in which the
stop codon at aa position 220 of NS1 was changed from TGA to
CGA. This alteration extended the NS1 C-terminus to the natural
stop codon at aa position 230 without affecting the NS2 open
reading frame (ORF). The plasmids pcDNA-Mex NS1/219,
pcDNA-Mex NS1/230, pEGFP-Mex NS1/219, pEGFP-Mex
NS1/230, pCMV-Mex NS1/219 and pCMV-Mex NS1/230
were constructed by ligating the PCR-amplified cDNAs contain-
ing different-length NS1 ORFs from the Mex strain into the
plasmids pcDNA3.1, pEGFP-N1 or pCMV-Tag2B. The plasmids
pcDNA-GST and pMYC-PABII were constructed by ligating the
PCR-amplified cDNA of GST or PABII into the plasmids
pcDNA3.1 or p-C-MYC.
Virus generation by reverse genetics
An 8-plasmid reverse genetics system was used to generate
recombinant viruses as described previously with some modifica-
tion [19]. 293T cells were co-transfected with the seven plasmids
(pHW-PR8 PB2, pHW-PR8 PB1, pHW-PR8 PA, pHW-PR8 HA,
pHW-PR8 NP, pHW-PR8 NA and pHW-PR8 M) encoding each
gene of virus A/PR/8/34 H1N1 (PR8) and plasmid pHW-Mex
NS or pHW-Mex mNS. Supernatants were collected at 60 h post-
transfection and injected into 10-day-old embryonated specific-
pathogen-free (SPF) chicken eggs. Allantoic fluids were collected at
72 h post-infection (p.i.) and then subjected to a hemagglutination
assay (HA). The generated recombinant viruses were named
rPR8-Mex NS1/219 and rPR8-Mex NS1/230.
Effects of the different-length NS1 protein on host gene
expression
A549 cells in 12-well plates were co-transfected with 0.05 mgo f
Renilla luciferase plasmid pRL-TK (Promega, WI) and 0.5 mgo f
the expression plasmid pcDNA-GST, pcDNA-Mex NS1/219 or
pcDNA-Mex NS1/230 using FuGENE HD (Roche, WI). At 24 h
post-transfection, Renilla luciferase expression was measured
according to the manufacturer’s instructions (Promega, WI), and
the total amounts of 219-aa NS1 and 230-aa NS1 protein
expression were measured by Western blotting using rabbit anti-
serum against a fusion protein of GST and Mex NS1/219,
monoclonal antibody against tubulin was used to detect tubulin
expression [20].
To test the effect of different-length NS1 protein on host
antiviral gene IFN-b expression in infected cells, confluent A549
cells in 6-well plates were infected with recombinant virus rPR8-
Mex NS1/219 or rPR8-Mex NS1/230 at a multiplicity of
infection (MOI) of 3 TCID50 per cell, or equal volum of DMEM
as control. At 6, 12 and 24 h p.i., the total RNA was extracted with
RNeasy mini kit (Qiagen, CA) from infected cells or mock cells
and subjected to DNase treatment (Qiagen, CA). Host antiviral
gene IFN-b mRNA and viral M gene mRNA production were
detected by quantitative real-time PCR (qRT-PCR) as described
previously [21].
Intracellular localization of the different-length NS1
protein in transfected and infected cells
A549 cells in 6-well plates were transfected with 2.0 mgo f
plasmid pEGFP-Mex NS1/219 or pEGFP-Mex NS1/230 using
FuGENE HD (Roche, WI). At 24 h post-transfection, cells were
imaged by an inverted fluorescence microscope (Olympus IX70,
Japan).
To study intracellular localization of different-length NS1
protein in infected cells, A549 cells were infected with viruses
rPR8-Mex NS1/219 or rPR8-Mex NS1/230 at an MOI of 3
TCID50 per cell. At 8 h p.i., cells were fixed with 4%
paraformaldehyde, permeabilized with 0.5% Triton X-100 and
incubated for one hour with 2% bovine serum albumin. NS1-
specific rabbit anti-serum incubation was performed overnight at
4uC followed by FITC-labelled goat anti-rabbit IgG and 49,6-
diamidino-2-phenylindole (DAPI). Cells were imaged on a
LSM510 Meta confocal laser scanning microscope.
Interaction of the different-length NS1 protein with PAB
II
293T cells in 6-well plates were co-transfected with 2.0 mg of the
MYC-tagged vector pMYC-PABII and 2.0 mg of the FLAG-
tagged vector pCMV-tag2B (empty vector), pCMV-Mex NS1/219
or pCMV-Mex NS1/230 using FuGENE HD (Roche, WI). Cells
were lysed in 50 mM Tris-HCl (pH 7.8), 500 mM NaCl, 5 mM
EDTA and 0.5% NP-40 supplemented with a protease inhibitor
cocktail (Amresco) and subjected to anti-FLAG affinity chroma-
tography at 48 h post-transfection. After being washed extensively,
the precipitated proteins were dissociated from the resin using
elution buffer and analyzed by SDS-PAGE followed by Western
blot with anti-FLAG (Abcam) and anti-MYC (Sigma) antibodies.
The proteins were visualized using a SuperSignal West Pico
(Pierce) and detected with a MF-ChemiBIS system (DNR).
In vitro characterization of the recombinant viruses
encoding different-length NS1 protein
Growth kinetics of the two recombinant viruses rPR8-Mex
NS1/219 and rPR8-Mex NS1/230 was determined by inoculating
A549 or PK-15 cells at an MOI of 0.001 TCID50 per cell. One
hour after inoculation, cells were washed twice with PBS and fresh
medium containing 0.1 mg/ml tosylsulfony phenylalanyl chlor-
omethyl ketone (TPCK)-trypsin (Sigma) was added. Supernatants
were sampled at 12, 24, 36 and 48 h p.i., and virus titers were
determined by calculating the log10TCID50/ml in MDCK cells.
The NS1 C-Terminal Truncation
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NS1/219 and rPR8-Mex NS1/230 was performed by inoculating
confluent MDCK cells in 6-well plates with appropriate dilutions
of viruses in DMEM for 1 h. Cells were washed twice with PBS
and then overlaid with DMEM (without phenol red, HyClone)-
0.8% agarose mixture containing 1% bovine serum albumin and
1 mg/ml TPCK-trypsin. After incubated at 37uC for 4 days, a
second agar overlay containing 1:10,000 neutral red was added
[17].
Mouse experiments
Animal studies were performed according to protocols approved
by the Hubei Provincial Animal Care and Use Committee
(approval number: SYXK 2010-0029).
The fifty percent mouse lethal dose (MLD50) titers were
determined by inoculating groups of four 5-week-old female
BALB/c mice intranasally (i.n.) with 50 ml of serial 10-fold
dilutions of the virus rPR8-Mex NS1/219 or rPR8-Mex NS1/230.
Titers were expressed as the log10TCID50 required to achieve 1
MLD50.
In a separate experiment, groups of mice were infected i.n. with
50 mlo f1 0
2 TCID50 of the recombinant virus rPR8-Mex NS1/
219 or rPR8-Mex NS1/230. Body weights of five mice in each
group were measured for either 14 days p.i. or until the loss of
30% of their body weight, at which point they were euthanized.
The survival percentage of four mice in each group was monitored
until 14 days p.i.. At days 3 and 6 p.i., six mice in each group were
sacrificed, and the lungs were removed; three lungs were fixed
with formalin, embedded in paraffin and stained with hematoxylin
and eosin (HE), while the other three lungs were homogenized in 1
ml PBS to determine virus titers (log10TCID50/ml) in MDCK
cells. For microarray analysis of mouse lungs infected with
recombinant virus rPR8-Mex NS1/219 or rPR8-Mex NS1/230,
at days 3 p.i., the lungs of three mice in each group were removed
and subjected to microarray analysis (Affymetrix) as described
previously [22]. The results of microarray data were confirmed by
qRT-PCR as described previously [22].
Results
The C-terminal truncated NS1 of the 2009 pandemic virus
was unable to block host gene expression
The NS1 of the classical swine H1N1 influenza virus was
maintained at a length of 230 aa until the mid-1960s, a stop codon
Figure 1. Inhibition of host gene expression by different-length NS1 protein. (A) A549 cells were co-transfected with Renilla luciferase
plasmid pRL-TK and expression plasmid pcDNA-GST, pcDNA-Mex NS1/219 or pcDNA-Mex NS1/230. Renilla luciferase expression was measured at 24
h post-transfection. The results showed the means and standard deviations of triplicate values (normalized to GST). The statistical analysis was
performed using Student’s t test (ww, p,0.01; w, p,0.05). (B) The 219-aa NS1 and 230-aa NS1 protein expression at 24 h post-transfection in
transfected A549 cells was detected by Western bloting using rabbit anti-serum against a fusion protein of GST and Mex NS1/219, tubulin was used
as control. (C) A549 cells were infected at an MOI of 3 TCID50 per cell. At 6, 12 and 24 h p.i., host antiviral gene IFN-b mRNA and viral M gene mRNA
production was deteced by qRT-PCR. The statistical analysis was performed using Student’s t test (ww, p,0.01; w, p,0.05).
doi:10.1371/journal.pone.0026175.g001
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terminus [23]. This 219-aa NS1 has subsequently been predom-
inant in the classical swine H1N1 influenza viruses and emerged in
the 2009 pandemic H1N1 influenza virus. To test whether the C-
terminal 11-aa truncation in NS1 of the 2009 pandemic virus has
any effects on host gene expression, we co-transfected Renilla
luciferase plasmid pRL-TK with expression plasmid pcDNA-
GST, pcDNA-Mex NS1/219 or pcDNA-Mex NS1/230. At 24 h
post-transfection, Renilla luciferase expression and the total
amounts of NS1 protein expression were determined. As shown
in Figure 1, similar amounts of 219-aa NS1 and 230-aa NS1 were
expressed in the transfected cells (Figure 1B), while the 230-aa NS1
significantly increased the inhibition of host gene expression than
did the 219-aa NS (Figure 1A).
We also meassured the antiviral gene IFN-b mRNA production
in A549 cells infected with recombinant virus rPR8-Mex NS1/219
or rPR8-Mex NS1/230 by qRT-PCR. Viral M gene mRNA
production was similar at each time point, while the antiviral gene
IFN-b mRNA production was higher when cells were infected
with virus rPR8-Mex NS1/219 than with virus rPR8-Mex NS1/
230 (Figure 1C).
In addition, the effect on host gene expression in vivo of the C-
terminal 11-aa truncation in NS1 of the 2009 pandemic virus was
evaluated. Microarray analysis of infected mouse lungs at days 3
p.i. showed that the recombinant virus rPR8-Mex NS1/219
induced higher levels of pro-inflammatory cytokines and
chemokines in mice lungs than did virus rPR8-Mex NS1/230
(Table 1).
The NS1 C-terminal 11-aa truncation did not alter
intracellular localization in transfected or infected cells
Certain critical amino acids (219K, 220R, 224R and 229K) at
the C-terminus of NS1 constitute an NoLS [18]. To determine
whether the inefficient blocking of host gene expression by the C-
terminal 11-aa truncated NS1 of the 2009 pandemic virus was
associated with the loss of NoLS, intracellular localization of
different-length NS1 from the 2009 pandemic virus in transfected
and infected A549 cells was analysed. As shown in Figure 2, both
Table 1. A validation of microarray data by qRT-PCR.
Gene
Microarray fold change
(fold change.2.0, q-value ,0.05)
qRT-PCR fold
change
CXCL1 2.02 5.73
CXCL2 3.47 16.42
CXCL5 2.86 14.27
CXCL9 2.45 4.64
CCL7 2.13 3.24
CCL8 2.28 5.43
IFN-c 2.63 7.6
IL1b 3.14 10.15
Clec4e 3.75 7.48
Clec4d 2.81 12.95
Clec5a 2.16 4.87
Stfa2l1 4.07 26.6
doi:10.1371/journal.pone.0026175.t001
Figure 2. Intracellular localization of different-length NS1 protein in transfected or infected cells. (A) A549 cells were transfected with
the plasmid pEGFP-Mex NS1/219 or pEGFP-Mex NS1/230. At 24 h post-transfection, cells were imaged using an inverted fluorescence microscope. (B)
A549 cells were infected with recombinant virus rPR8-Mex NS1/219 or rPR8-Mex NS1/230 at an MOI of 3 TCID50 per cell. At 8 h p.i., cells were fixed
with 4% paraformaldehyde, permeabilized with 0.5% Triton X-100 and incubated for one hour with 2% bovine serum albumin. An NS1-specific rabbit
anti-serum incubation was performed overnight at 4uC followed by FITC-labelled goat anti-rabbit IgG and DAPI. Cells were imaged on an LSM510
Meta confocal laser scanning microscope.
doi:10.1371/journal.pone.0026175.g002
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and cytoplasm, but not nucleolus. These results demonstrated that
the inefficient blocking of host gene expression by the C-terminal
11-aa truncated NS1 of the 2009 pandemic virus was not
associated with nucleolar localization.
C-terminal truncated NS1 from the 2009 pandemic virus
lost PABII-binding capacity
PABII is involved in host pre-mRNA processing and nuclear
export of host mRNA. The C-terminal 223-230 aa of influenza
virus NS1 constitute PABII-binding domain [5], and the binding
of NS1 to PABII results in inhibition of host pre-mRNA
maturation. To determine whether the C-terminal 11-aa truncat-
ed NS1 of the 2009 pandemic virus lost the PABII-binding
capacity, co-precipitations of FLAG-tagged NS1/219 or NS1/230
with MYC-tagged PABII were performed. The results showed that
FLAG-NS1/219 did not coprecipitate with PABII, while FLAG-
NS1/230 clearly bound to PABII (Figure 3). Analysis of whole-cell
lysates confirmed similar expression levels of the input proteins
(Figure 3). These data demonstrated that the inefficient inhibition
of host gene expression for NS1/219 was probably due to the loss
of PABII-binding capacity.
In vitro characterization of the recombinant viruses with
different-length NS1 protein
To determine whether the C-terminal 11-aa truncation in NS1
of the 2009 pandemic virus altered virus replication in vitro, the
growth property in A549 and PK-15 cells and plaque-forming
capacity in MDCK cells of the recombinant viruses rPR8-Mex
NS1/219 and rPR8-Mex NS1/230 were determined. As shown in
Figure 4, The two recombinant viruses exhibited similar growth
kinetics in A549 and PK-15 cells (Figure 4A), and formed similar-
size plaques in MDCK cells (Figure 4B).
The NS1 C-terminal 11-aa truncation enhanced virus
pathogenicity in mice
MLD50 assays were performed by inoculating groups of four
mice with serial 10-fold dilutions of the recombinant virus rPR8-
Mex NS1/219 or rPR8-Mex NS1/230. Virus rPR8-Mex NS1/
219 displayed slightly lower MLD50 titer than virus rPR8-Mex
NS1/230 (1.5 or 1.9 log10TCID50, respectively). To determine the
morbidity (measured by body weight loss) and mortality, groups of
mice were infected i.n. with 10
2 TCID50 of virus rPR8-Mex NS1/
219 or rPR8-Mex NS1/230. The data showed that virus rPR8-
Mex NS1/219 caused more rapid body weight loss and resulted in
death earlier than did virus rPR8-Mex NS1/230 (Figure 5A and
5B). Histological analysis of infected mouse lung tissues showed
that virus rPR8-Mex NS1/219-infected tissues exhibited more
severe hemorrhage and alveolitis than did tissues infected with
virus rPR8-Mex NS1/230 (Figure 5D). When growth property of
virus rPR8-Mex NS1/219 and rPR8-Mex NS1/230 was assessed
in mouse lungs, virus rPR8-Mex NS1/219 grew to slightly, but not
significantly higher titers than virus rPR8-Mex NS1/230 at days 3
and 6 p.i. (Figure 5C).
Figure 3. Interactions of different-length NS1 protein with
PABII. 293T cells were co-transfected with the MYC-tagged vector
pMYC-PABII and the FLAG-tagged vector pCMV-tag2B (empty vector),
pCMV-Mex NS1/219 or pCMV-Mex NS1/230. At 48 h post-transfection,
cells were lysed, supplemented with a protease inhibitor cocktail and
subjected to anti-FLAG affinity chromatography. After extensive
washing, the precipitated proteins were dissociated from the resin
using elution buffer and analyzed by SDS-PAGE followed by Western
bloting with anti-FLAG and anti-MYC antibodies. The proteins were
visualized using a SuperSignal West Pico and detected with a MF-
ChemiBIS system (DNR). PD: Pull Down.
doi:10.1371/journal.pone.0026175.g003
Figure 4. In vitro characterization of the recombinant viruses
encoding different-length NS1 protein. (A) A549 or PK-15 cells
were infected at an MOI of 0.001 TCID50 per cell. After washed with PBS,
fresh medium containing 0.1 mg/ml TPCK-trypsin was added. Superna-
tants were sampled at 12, 24, 36 and 48 h p.i. and virus titers were
determined as log10TCID50/ml in MDCK cells. The statistical analysis was
performed using Student’s t test. (B) Virus plaque assay was performed
by inoculating confluent MDCK cells in 6-well plates with appropriate
dilutions of viruses. After washed with PBS, cells were overlaid with
DMEM (without phenol red)-0.8% agarose mixture containing 1%
bovine serum albumin and 1 mg/ml TPCK-trypsin. After incubated at
37uC for 4 days, a second agar overlay containing 1:10,000 neutral red
was added.
doi:10.1371/journal.pone.0026175.g004
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The NS1 protein of influenza A viruses has attracted much
attention because of its multifunctional role. Recent reports have
showed that the 2009 pandemic virus induced higher amounts of
pro-inflammatory cytokines and chemokines in mammalian
models than human seasonal H1N1 influenza viruses [3]. In this
study, we focused on the C-terminal 11-aa truncation in NS1 of
the 2009 pandemic virus. Renilla luciferase expression was used to
mimic host gene expression [20], and the results showed that the
C-terminal 11-aa truncated NS1 of the 2009 pandemic virus was
inefficient at blocking host gene expression, while extension of the
truncated NS1 to its full length increased the inhibition of host
gene expression. This characterization was further confirmed in
A549 cells and mice lungs infected with recombinant virus rPR8-
Mex NS1/219 or rPR8-Mex NS1/230. The recombinant virus
rPR8-Mex NS1/219 induced higher amounts of IFN-b mRNA
production in A549 cells and higher levels of pro-inflammatory
cytokines and chemokines in mice lungs than did virus rPR8-Mex
NS1/230 (Table 1).
The C-terminal 219-230 aa of H3N2 influenza virus NS1
constitute an NoLS as the four critical amino acids are 219K,
220R, 224R and 229K [18]. Whereas, this is not a case for the
H1N1 influenza virus A/WSN/33, of which the four critical
amino acids are 219K, 220R, 224G and 229E. Single mutation
G224R or double mutations G224R and E229K in NS1 of virus
A/WSN/33 led to partial or full nucleolar localization [18].
Extension of the 219-aa NS1 of the 2009 pandemic virus to its full
length resulted in the four critical amino acids being 219K, 220R,
224R and 229E. Interestingly, the full-length NS1 did not show
partial nucleolar localization in transfected or infected cells. Hale
et al. [24] recently identified a new key residue 221K involved in
nucleolar localization of NS1 protein. Although the residue 221K
was observed in both MSN NS1 and Mex NS1/230, the failure of
Figure 5. Pathogenicity and growth property of the recombinant viruses encoding different-length NS1 protein in mice. Groups of
mice were inoculated i.n. with 50 mlo f1 0
2 TCID50 of the recombinant virus rPR8-Mex NS1/219 or rPR8-Mex NS1/230. (A) Body weight of five mice in
each group was measured for either 14 days p.i. or until the loss of 30% of their body weight. The statistical analysis was performed using Student’s t
test (ww, p,0.01; w, p,0.05). (B) The survival percentage of four mice in each group was monitored for 14 days p.i.. (C) At days 3 and 6 p.i., three
mice in each group were sacrificed, lungs were removed and homogenized in 1 ml PBS to determine virus titers by log10TCID50/ml in MDCK cells. (D)
At days 3 and 6 p.i., three mice in each group were sacrificed and lungs were fixed with formalin, embedded in paraffin and stained with hematoxylin
and eosin. Images were captured at 40X magnification.
doi:10.1371/journal.pone.0026175.g005
The NS1 C-Terminal Truncation
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26175nucleolar localization for Mex NS1/230 might be due to other
unidentified key residues, which were involved in nucleolar
localization and different between WSN and Mex NS1.
PABII is involved in cellular pre-mRNA processing, binding of
influenza virus NS1 to PABII results in the nuclear accumulation
of cellular pre-mRNAs containing short poly(A) tail [9]. The C-
terminal 223-230 aa of influenza virus NS1 constitute PABII-
binding domain [5]. Here, we determined that the C-terminal 11-
aa truncation of NS1 from the 2009 pandemic virus resulted in the
loss of NS1’s PABII-binding capacity, extension of the truncated
NS1 to its full length restored its PABII-binding capacity. Thus,
the increased inhibition of host gene expression of 230-aa NS1
might be due to the restoration of its PABII-binding capacity.
It has been reported that the four C-terminal residures of NS1
protein in most human and animal influenza viruses formed an X-
S/T-X-V type PDZ ligand motif [25], which has been reported to
be associated with virus virulence [26–29]. Extension of the 219-aa
NS1 of the 2009 pandemic virus to 230-aa resulted in an NS1
protein encoding a GTEI motif at aa 227-230, which is not a PDZ
ligand motif. However, the effects of the C-terminal 11-aa
truncation of the NS1 protein from the 2009 pandemic virus on
virus replication and pathogenicity have attracted much attention
recently. Hale et al. [23] indicated that the C-terminal 11-aa
truncation in NS1 did not alter the replication or virulence of the
2009 pandemic virus, authors [23] speculated that the biological
effects of the C-terminal 11-aa truncation in NS1 would be more
apparent if different virus strains or host species were used, as the
genetic constellation of the 2009 pandemic virus might already be
optimized to function efficiently. In this study, the laboratory
strain PR8 was chosen as backbone to generate two ‘‘7+1’’
recombinant viruses expressing either 219-aa or 230-aa NS1 from
the 2009 pandemic virus. Our studies showed that the C-terminal
11-aa truncation in NS1 enhanced virus pathogenicity in mice,
which was consistent with the reports of Ozawa et al. that the C-
terminal 11-aa truncation in NS1 of the 2009 pandemic virus
increased virus virulence in mice [30].
In summary, we determined that the C-terminal-truncated NS1
of the 2009 pandemic virus was inefficient at blocking host gene
expression, extension of the truncated NS1 to its full length
increased the inhibition of host gene expression, restored its
binding capacity to PABII, but decreased virus pathogenicity in
mice.
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